Friday, August 05, 2011 6:51:40 PM
Excerpt from Street Sweeper article on ADHC a month or so ago.
According to the disclaimer of a promoter from this Wednesday, the compensation for the advertising service is $25,000 in cash to be paid by a third part each month for a total of 18 months. That sums up to a large amount of money to be spent on promoting ADHC, suggesting that the paying part might be a large shareholder of the company//////end excerpt/////////////
Why would someone pay $25k a month for 18 months of promotions unless they had some very positive inside info. Deal will still roll very, very soon the way I see it.
According to the disclaimer of a promoter from this Wednesday, the compensation for the advertising service is $25,000 in cash to be paid by a third part each month for a total of 18 months. That sums up to a large amount of money to be spent on promoting ADHC, suggesting that the paying part might be a large shareholder of the company//////end excerpt/////////////
Why would someone pay $25k a month for 18 months of promotions unless they had some very positive inside info. Deal will still roll very, very soon the way I see it.
Recent ADHC News
- American Diversified Holdings Operating Division GlucoGuard Retains Global Contract Research Organization (CRO) to Begin Patient Studies as Required by the FDA • Newsfile • 04/01/2026 12:30:00 PM
- American Diversified Holdings Corporation (ADHC) Announces Internal Technology Initiative Within Universal Wellness AI Division • Newsfile • 01/06/2026 02:00:00 PM
- GlucoGuard a Division of American Diversified Holdings (ADHC) Successfully Submits Level 2 App Integration Through Dexcom's Developer Partner Program • Newsfile • 11/25/2025 02:00:00 PM
- GlucoGuard Receives $43 Million Enterprise Valuation From Prominent CFA Led Harbinger Research • Newsfile • 11/04/2025 02:00:00 PM
- American Diversified Holdings Corporation Receives $5,000,000 (Five Million) Financing Commitment from an Institutional Investment Fund • Newsfile • 10/16/2025 01:00:00 PM
- GlucoGuard Receives Scope of Work (SOW) Proposal from Arete Bioscience for FDA Recommended Sleep Study • Newsfile • 10/14/2025 10:00:00 AM
